Advertisement

Topics

UK’s Regulatory Agency Grants Promising Innovative Medicine Designation to 'Bubble Baby' Disease Treatment

08:00 EDT 23 Aug 2017 | PharmPro

Orchard Therapeutics announces that OTL-101 has received a designation as promising innovative medicine by UK’s regulatory agency.
Contributed Author: 
Orchard Therapeutics
Topics: 

Original Article: UK’s Regulatory Agency Grants Promising Innovative Medicine Designation to 'Bubble Baby' Disease Treatment

NEXT ARTICLE

More From BioPortfolio on "UK’s Regulatory Agency Grants Promising Innovative Medicine Designation to 'Bubble Baby' Disease Treatment"

Advertisement
Quick Search
Advertisement
Advertisement